ArticleMolecular cancer research : MCR2022

MYC Promotes Tyrosine Kinase Inhibitor Resistance in ROS1-Fusion-Positive Lung Cancer.

Sudarshan R Iyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.